Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Dimensional Fund Advisors Ltd. : Form 8.3 - CREST NICHOLSON HOLDINGS - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BELLWAY PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
-
OKX Introduces New USDC Spot Trading Pairs to Support the Growth of the USDC Ecosystem
-
Form 8.5 (EPT/RI) - Touchstone Exploration Inc.
-
Up-and-Coming Chinese Skincare Expert PMPM Bags International Industry Influential Brand Award at United Nations Forum
-
Form 8.5 (EPT/RI) - musicMagpie Plc
-
Yiren Digital Releases 2023 ESG Report
-
Digital Technology Boosts Rural Areas in Tongzhou, Nantong City
-
Form 8.5 (EPT/RI) - Global Ports Holding Plc
-
Form 8.5 (EPT/RI) - NewRiver REIT Plc
-
RESULT OF RIKSBANK AUCTIONS GOVERNMENT BONDS
-
Hanon Systems Releases 2023 Sustainability Report
-
Boldyn Networks turns one, connects over a billion people worldwide
-
Alessio Perrucci of ClimaConvenienza Wins Two 2024 Business Worldwide CEO Awards
-
Square Mile Coffee Roasters Announces Pilot Testing of Bellwether Coffee's Electric Roasting Technology To Expand Operations
-
Tutors are not there to spoon-feed students, but to equip them for independent learning, says Tutors International
-
Coforge Named 'Exceptional Performer' in Whitelane Research’s 2024 UK IT Sourcing Study
-
Sanoma will publish its Half-Year Report 2024 on 24 July
-
Argus appoints Maria Hooper to its board of directors
-
Unlock the Stability and Security of Windows 11 IoT Enterprise LTSC with Advantech's Edge Computing Platform
-
Regent Hong Kong Named #1 Best Hong Kong Hotel at the Travel + Leisure Southeast Asia Luxury Awards
-
Change in the number of shares and votes in Truecaller AB
-
Wondershare Filmora Releases Gen Z Whitepaper: 'Gen Z in Action: Exploring This Generation's Reflection on AI, Influencer Culture, and Content Creation'
-
Eisai: "LEQEMBI" (Lecanemab) for the Treatment of Alzheimer's Disease Launched in China
-
Changes in the Management Board of Enefit Green
-
Stephan Séjourné Joins MAX Power’s Natural Hydrogen Team
-
atNorth Recognized at RAC Cooling Industry Awards
-
"Captain Tsubasa: Dream Team" 7th Anniversary Campaign: Season 2 Kicks Off with the Ultimate Anniversary Superstar Transfer Featuring Limited Edition Superstars from the Brazil National Team
-
CCL Wins Technology Company of the Year at Multimodal Awards
-
Diane Wang Honored with CEO TODAY GLOBAL AWARDS 2024 for E-Commerce Pioneering and Women Empowerment
-
Q1 2024 Financial Results
-
OMNICOM MEDIA GROUP RETURNED FROM CANNES AS MOST HONORED MEDIA HOLD CO, PREFERRED PARTNER IN GAME-CHANGING COLLABORATIONS
-
Algorand celebrates 5th anniversary with 2 billion transactions and record adoption of real-world use cases at annual Decipher conference
-
All Seas Capital Backs Synergym to Fuel Expansion Plans
-
Municipality Finance issues a GBP 250 million benchmark under its MTN programme
-
Biovica Signs New Agreement Supporting Pharma Development
-
SNIPR Biome receives funding for the development of CRISPR-medicines to improve Environmental Enteric Dysfunction (EED) in pregnant women
-
Form 8.5 (EPT/RI) - Alpha Financial Markets Consulting Plc
-
Form 8.5 (EPT/RI) - Renalytix Plc
-
Share buyback programme - conclusion and implementation
-
Zealand Pharma completes registration of capital increase
-
Biovica International AB - Annual Report for the Financial Year 2023/2024 Published
-
IronDoge Announces its Upcoming Private Sale's Phase 2, Initiates Whitelisting for Early Investors
-
Autoliv Retires Repurchased Shares, Decreases Number of Issued Shares
-
Yard Force Introduces the 21W Portable Solar Charger with Dual USB Ports and 13000 mAh Built-in Battery
-
PGS ASA: Settlement of Long-term Incentive Plans
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - Jun 28
-
2024 ASCAP TOP RHYTHM & SOUL MUSIC AWARD WINNERS INCLUDE SONGWRITER OF THE YEAR LIL BABY, SONG OF THE YEAR "SNOOZE" AND PUBLISHER OF THE YEAR WARNER CHAPPELL
-
AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
